Used primarily in pharmaceutical research, this compound serves as a key intermediate in the synthesis of various therapeutic agents. Its structure is particularly valuable in the development of drugs targeting neurological disorders, including Alzheimer's disease and other cognitive impairments. Additionally, it is explored for its potential in creating anticancer medications, where its fluoropicolinamide moiety plays a crucial role in enhancing drug efficacy and specificity. Researchers also investigate its utility in designing radiopharmaceuticals for diagnostic imaging, leveraging its ability to bind selectively to certain biological targets.